{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:08:35Z","timestamp":1787771315445,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1002\/jps.22435","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T17:26:01Z","timestamp":1294248361000},"page":"2366-2378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Studies on Binary Lipid Matrix Based Solid Lipid Nanoparticles of Repaglinide: in Vitro and in Vivo Evaluation"],"prefix":"10.1016","volume":"100","author":[{"given":"Manoj K.","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achint","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22435_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(02)00051-9","article-title":"Lipid-based formulations for intestinal lymphatic delivery","volume":"15","author":"O'Driscoll","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.22435_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/A:1011975120776","article-title":"Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats","volume":"15","author":"Bargoni","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22435_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-5173(99)00166-0","article-title":"Synthesis and characterization of palmitoyl propranolol hydrochloride auto-lymphotrophs for oral administration","volume":"186","author":"Vyas","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0020","first-page":"2","article-title":"Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles","volume":"53","author":"Muhlen","year":"1998","journal-title":"Pharmazie"},{"key":"10.1002\/jps.22435_bb0025","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0169-409X(01)00182-X","article-title":"In vitro assessment of oral lipid based formulations","volume":"50","author":"Porter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22435_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(01)00152-1","article-title":"Recent advances in the understanding of uptake of microparticulate across the gastrointestinal lymphatics","volume":"50","author":"Hussain","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22435_bb0035","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int J Nanomed"},{"key":"10.1002\/jps.22435_bb0040","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jps.10129","article-title":"Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats","volume":"91","author":"Zara","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22435_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10611860600888850","article-title":"Pharmacokinetics, tissue distribution, and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"14","author":"Manjunath","year":"2006","journal-title":"J Drug Target"},{"key":"10.1002\/jps.22435_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1002\/jps.22435_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2006.05.010","article-title":"Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability","volume":"114","author":"Luo","year":"2006","journal-title":"J Control Release"},{"key":"10.1002\/jps.22435_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","article-title":"Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles","volume":"133","author":"Li","year":"2009","journal-title":"J Control Release"},{"key":"10.1002\/jps.22435_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22435_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1358\/mf.2005.27.2.876286","article-title":"Solid lipid nanoparticles as drug delivery systems","volume":"27","author":"Manjunath","year":"2005","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1002\/jps.22435_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejpb.2008.05.015","article-title":"Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution","volume":"71","author":"Windbergs","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22435_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(99)00426-3","article-title":"Comparison of wax and glycerides solid lipid nanoparticles","volume":"196","author":"Jenning","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/dmrr.185","article-title":"Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"17","author":"Mayer-Davis","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1002\/jps.22435_bb0090","first-page":"233","article-title":"Studies on biodegradable polymeric nanoparticles of risperidone: In vitro and in vivo evaluation","volume":"2","author":"Muthu","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1002\/jps.22435_bb0095","series-title":"Pharmacopeia","author":"US","year":"2006"},{"key":"10.1002\/jps.22435_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0928-0987(01)00186-5","article-title":"Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats","volume":"14","author":"Holm","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.22435_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0939-6411(98)00015-0","article-title":"Preparation and characterization of nanoparticles containing an antihypertensive agent","volume":"46","author":"Verger","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22435_bb0110","first-page":"305","article-title":"Preparation and characterization of nanoparticles containing an atypical antipsychotic agent","volume":"3","author":"Singh","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1002\/jps.22435_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1081\/PDT-100100550","article-title":"Formulation and evaluation of vinypyrrolidone\/vinylacetate copolymer microspheres with carbamazepine","volume":"5","author":"Moneghini","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.22435_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00408-6","article-title":"Pharmacodynamics of insulin in polyethylene glycol-coated liposomes","volume":"180","author":"Kim","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2008.09.008","article-title":"Formulation of an intravenous emulsion loaded with clarithromycin-phospholipid complex and its pharmacokinetics in rats","volume":"366","author":"Lu","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2003.09.014","article-title":"Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice","volume":"172","author":"Goldberg","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1002\/jps.22435_bb0135","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.biomaterials.2003.09.073","article-title":"Pharmacodynamic-pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models","volume":"25","author":"Adikwu","year":"2004","journal-title":"Biomaterials"},{"key":"10.1002\/jps.22435_bb0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(95)04286-5","article-title":"Crystallization tendency and polymorphic transitions in triglyceride nanoparticles","volume":"129","author":"Bunjes","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","article-title":"Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids","volume":"199","author":"Jenning","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J Control Release"},{"key":"10.1002\/jps.22435_bb0155","first-page":"S31","article-title":"Characterization of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne","volume":"23","author":"Gisele","year":"2008","journal-title":"Powder Diffr"},{"key":"10.1002\/jps.22435_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00404-9","article-title":"Enzymatic degradation of SLN\u2014effect of surfactant and surfactant mixtures","volume":"180","author":"Olbrich","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules","volume":"27","author":"Garcia-Fuentes","year":"2003","journal-title":"Colloid Surf B Biointerfaces"},{"key":"10.1002\/jps.22435_bb0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"Roger","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013A review of the state of the art","volume":"50","author":"Muller","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22435_bb0180","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22435_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2006.11.004","article-title":"Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glycerid lipids on plasma pharmacokinetics","volume":"335","author":"Kumar","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22435_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.22435_bb0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/17435889.2.2.219","article-title":"Doxorubicin\u2013loaded PLGA nanoparticles by nanoprecipitation: Preparation, characterization and in vitro evaluation","volume":"2","author":"Betancourt","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1002\/jps.22435_bb0200","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-2275(20)33863-3","article-title":"Intracellular movement of triacylglycerols in intestine","volume":"39","author":"Mansbach","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1002\/jps.22435_bb0205","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jps.10368","article-title":"Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin","volume":"92","author":"Cavalli","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22435_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00147-8","article-title":"An examination of the factors affecting intestinal lymphatic transport of dietary lipids","volume":"50","author":"Nordskog","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22435_bb0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0021-9150(00)00456-1","article-title":"Intestinal absorption of triglyceride and cholesterol, dietary and pharmacological inhibition to reduce cardiovascular risk","volume":"151","author":"Ros","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1002\/jps.22435_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.02.045","article-title":"Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN) versus drug nanocrystals","volume":"317","author":"Mullar","year":"2006","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:22:56Z","timestamp":1758360176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915320980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022354915320980"],"URL":"https:\/\/doi.org\/10.1002\/jps.22435","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studies on Binary Lipid Matrix Based Solid Lipid Nanoparticles of Repaglinide: in Vitro and in Vivo Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.22435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Wiley-Liss, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}